VIENNA – FDG-PET/CT can identify a possible primary tumor in patients with carcinoma with unknown primary tumor (CUP) syndrome at a rate comparable to that found in autopsy studies, German researchers reported on Monday at ECR 2014. {read more here}

Preliminary data regarding the first known human trial involving glutamine PET for the detection of glioma showed encouraging pharmacokinetics and biodistribution, according to researchers presenting at this year’s European Congress of Radiology (ECR). {read more here}

The American College of Radiology applauds steps to reign in medical imaging and radiation oncology self-referral included in the President’s Fiscal Year 2015 budget[1]. However, prior authorization for imaging services, also included the FY 2015 budget, is unnecessary and will ultimately raise costs, interfere in the doctor-patient relationship and restrict ready access to imaging care. {read more here}

Researchers have developed a new imaging technique that lights up cancer’s sleeper cells, warning patients and doctors of a potential relapse according to a study published in Cancer Research today.  Cancer cells can enter a sleeping state when they stop growing and instead store energy for future use – much more so than most normal healthy cells. But by using a radioactive molecule which mimics what our body uses to create energy, the researchers could measure the build up of these energy stores, known as glycogen, using positron emission tomography (PET scan). {read more here}